Marketplace Materials

post

Case Study: Phase II MS Trial

A large, global sponsor was facing increasing internal competition and needed a way to confidently expand their site network. This sponsor was also looking to broaden their geographic reach and access diverse patients. Find out how partnering with community-based sites through Inato's Marketplace accomplished all of these goals and more.
post

Case Study: Phase III AAD Trial

A large, global sponsor was experiencing difficulties in hitting enrollment numbers for an Agitation in Alzheimer's Dementia trial. Having closed many sites due to slow enrollment, the study team needed help in identifying experienced sites with access to their target patient population. The sponsor collaborated with Inato to access untapped patient populations and identify qualified sites that could enroll patients in just two months. Discover how partnering with Inato allowed them to meet their trial goals and accelerate their timeline.
post

Case Study: Portfolio Collaboration

A global sponsor was facing challenges in their trials brought on by the COVID-19 pandemic. With an increase of competition at large research sites and a decrease in patients visiting their physicians they sought out an alternative solution to eliminate trial obstacles. The sponsor's collaboration with Inato broadened their access to diverse patient populations and boosted the efficiency of their studies. Find out how Inato's network of community-based sites allowed this sponsor overcome trial delays and hit their targets.
post

Inato Company Overview

Looking for reliable site performance? Learn more about how Inato help. By connecting to Inato's verified network of community sites, sponsors can accelerate activation, increase enrollment, and create more inclusive research.
post

Inato's Inclusive Research Program

In recent history, we've made some incredible medical innovations through trials. But not everyone has access. Let's change that. Throughout the world, if you fall within a minority or otherwise marginalized group, it's not only more likely that you won't have access to clinical trial research but also that a breakthrough drug hasn't been adequately tested on people of your ethnicity or background. Sponsors want their trials to be inclusive because it leads to more robust analysis, faster drug approvals, and improved patient outcomes. However, it's not always easy to engage underserved patients in research. That's where community sites come in. By partnering with investigators who already have trusted relationships with patients and deep ties to the community, sponsors can reach untapped patient populations. **Inato's Inclusive Research Program connects sponsors with proven-diverse sites, making sure the latest medical innovations are safe and effective for everyone.**
post

Introducing the Inato Verified Commitment

Today, sponsors have little visibility into the process sites use to create enrollment estimates. We can fix that. For sponsors, the current process means two sites committing to the same number of patients could prove to have wildly different results. So how do you know which one to select? Take the guess work out of planning with the Inato Verified Commitment. Our team conducts a probability analysis to determine the likelihood that a site can enroll a given number of patients and only awards a verified commitment when we are at least 80% confident that the site will reach their goals. Download our one-pager to learn more about increasing the predictability of your next trial.